Product Program year 2025 Source: CMS Open Payments

Femostop

Device Vascular

PDI 05414734050036

Open in the dashboard

General payments

$20,168

169 payments

Research payments

$0

0 payments

Through program year 2025, $20,168 in general payments and $0 in research payments were reported against Femostop (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $1,060 55
2024 General $10,504 55
2023 General $3,556 38
2022 General $5,047 21

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $20,168 169 payments
Top recipients General payments · program year 2025
  1. Peter Farrugia Cardiovascular Disease · Colts Neck, NJ $42 4% · 2 payments
  2. David Spinosa Diagnostic Radiology · Fairfax, VA $32 3% · 1 payment
  3. Kara Turpin Clinical Cardiac Electrophysiology · Rock Hill, SC $28 3% · 1 payment
  4. Andrea Talukdar Pediatric Critical Care Medicine · Madison, WI $25 2% · 1 payment
  5. Alexa Paley Physician Assistant · Omaha, NE $25 2% · 1 payment

The top 5 of 53 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $170 18% · 9 practitioners
  2. Interventional Cardiology Internal Medicine $124 13% · 7 practitioners
  3. Physician Assistant $101 11% · 5 practitioners
  4. Physician Assistant, Medical Physician Assistant $77 8% · 4 practitioners
  5. Clinical Cardiac Electrophysiology Internal Medicine $68 7% · 3 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $206 19% · 9 recipients
  2. New York $158 15% · 10 recipients
  3. Oklahoma $85 8% · 5 recipients
  4. Illinois $65 6% · 4 recipients
  5. New Jersey $64 6% · 2 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

169 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record